L-carnitine is metabolized primarily in the liver and kidneys, where it undergoes conversion into various metabolites. The major pathway involves conversion to TMAO by gut bacteria, emphasizing the need for understanding individual variations in gut microbiota that can influence the metabolism and potential toxicity of L-carnitine.
